NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nuvectis Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$18.94+0.34 (+1.83%)
Close on Oct 19, 2026
- Market cap
- $444.64M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
31.5%
10M of 33M shares
Institutional holders
83
29 new, 6 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $1.79M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Thomas Peters | 908,475 | 5.20% | 13G (passive) amendment | Dec 31, 2023 |
| Charles Mosseri-Marlio | 2,595,000 | 15.00% | 13G (passive) amendment | Dec 31, 2023 |
| Levy Guy | 1,648,024 | 5.10% | 13G (passive) | Aug 4, 2026 |
| Enrique Poradosu | 1,503,819 | 8.70% | 13G (passive) amendment | Dec 31, 2023 |
| Shay Shemesh | 1,491,955 | 8.60% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NVCT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 1,550,000 | 4.76% | $28.50M | New | 1.29% |
| BlackRock, Inc. | 1,001,285 | 3.07% | $18.41M | +236,844 | 0.00% |
| Perceptive Advisors LLC | 1,000,000 | 3.07% | $18.39M | New | 0.28% |
| Soleus Capital Management, L.P. | 1,000,000 | 3.07% | $18.39M | New | 0.63% |
| Vanguard Capital Management LLC | 872,482 | 2.68% | $16.04M | +212,603 | 0.00% |
| Iridian Asset Management LLC/Ct | 777,078 | 2.39% | $14.29M | +125,321 | 4.91% |
| Geode Capital Management, LLC | 432,273 | 1.33% | $7.95M | +48,168 | 0.00% |
| Sphera Funds Management Ltd. | 382,945 | 1.18% | $7.04M | New | 0.92% |
| Baldwin Brothers LLC/Ma | 382,015 | 1.17% | $7.03M | +3,390 | 0.46% |
| Occam Crest Management LP | 357,147 | 1.10% | $7.39M | −50,000 | 3.84% |
| Alyeska Investment Group, L.P. | 275,000 | 0.84% | $5.06M | New | 0.01% |
| State Street Corp | 248,198 | 0.76% | $4.56M | +81,682 | 0.00% |
| Susquehanna International Group, Llp | 217,286 | 0.67% | $4.00M | +112,000 | 0.00% |
| Avidity Partners Management LP | 200,000 | 0.61% | $3.68M | New | 0.59% |
| Kalehua Capital Management LLC | 200,000 | 0.61% | $3.68M | New | 1.17% |
| Northern Trust Corp | 146,714 | 0.45% | $2.70M | +22,502 | 0.00% |
| Vanguard Fiduciary Trust Co | 127,554 | 0.39% | $2.35M | +12,712 | 0.00% |
| Vanguard Portfolio Management LLC | 118,297 | 0.36% | $2.18M | +26,143 | 0.00% |
| Citadel Advisors LLC | 115,532 | 0.35% | $2.12M | +37,107 | 0.00% |
| Oppenheimer & Co Inc | 73,566 | 0.23% | $1.35M | – | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 83 | 10M | 31.5% | 29 / 34 | 11 / 6 | 6M | 0M |
| Q1 2026 | 62 | 4M | 13.8% | 17 / 20 | 9 / 1 | 1M | 0M |
| Q4 2025 | 48 | 4M | 13.0% | 3 / 25 | 9 / 8 | 1M | 0M |
| Q3 2025 | 53 | 4M | 11.4% | 11 / 14 | 14 / 5 | 1M | 0M |
| Q2 2025 | 47 | 3M | 10.0% | 22 / 15 | 6 / 8 | 2M | 0M |
| Q1 2025 | 33 | 2M | 6.3% | 10 / 13 | 3 / 8 | 1M | 0M |
| Q4 2024 | 31 | 1M | 4.1% | 7 / 14 | 8 / 7 | 0M | 0M |
| Q3 2024 | 31 | 1M | 3.2% | 4 / 9 | 11 / 13 | 0M | 0M |
| Q2 2024 | 41 | 1M | 3.7% | 17 / 10 | 12 / 16 | 0M | 1M |
| Q1 2024 | 40 | 2M | 5.1% | 6 / 16 | 11 / 2 | 0M | 0M |
| Q4 2023 | 36 | 2M | 4.7% | 5 / 17 | 6 / 2 | 0M | 0M |
| Q3 2023 | 33 | 1M | 3.9% | 1 / 14 | 13 / 5 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NVCT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 482,087 | 1.48% | $8.87M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 430,791 | 1.32% | $7.92M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 198,560 | 0.61% | $3.65M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 187,295 | 0.57% | $4.03M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 158,261 | 0.49% | $2.91M | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 90,494 | 0.28% | $882.32K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 79,738 | 0.24% | $777.45K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 56,577 | 0.17% | $1.04M | 0.07% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 41,533 | 0.13% | $893.79K | 0.01% | Jul 31, 2026 |
| Master Small Cap Index Series | 33,444 | 0.10% | $615.04K | 0.01% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 31,399 | 0.10% | $306.14K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 28,065 | 0.09% | $273.63K | 0.00% | May 31, 2026 |
| Nuveen Small Cap Blend Index Fund | 22,674 | 0.07% | $487.94K | 0.01% | Jul 31, 2026 |
| Nuveen Equity Index Fund | 18,149 | 0.06% | $390.57K | 0.00% | Jul 31, 2026 |
| EQ/2000 Managed Volatility Portfolio | 18,102 | 0.06% | $332.90K | 0.01% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ron Bentsur | Chairman & CEO, Director, 10% owner | 3,688,424 | 11.32% | Jul 1, 2026 |
| Michael J. Carson | Vice President, Finance | 230,118 | 0.71% | Aug 5, 2026 |
| Shay Shemesh | Chief Dev. & Ops. Officer | 1,793,068 | 5.50% | Jan 9, 2026 |
| Enrique Poradosu | Chief Science & Business Off | 1,806,319 | 5.54% | Jan 9, 2026 |
| Juan Sanchez | Director | 113,795 | 0.35% | Jun 12, 2026 |
| Kenneth Hoberman | Director | 168,140 | 0.52% | Jun 12, 2026 |
| James F. Oliviero III | Director | 122,828 | 0.38% | Jun 12, 2026 |
| Matthew L. Kaplan | Director | 159,760 | 0.49% | Jun 12, 2026 |
| Marlio Charles Mosseri | 10% owner | 3,295,897 | 10.12% | Jul 1, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael J. Carson Vice President, Finance | Aug 3, 2026 | Award | +30,000 | – | – | 230,118 |
| Marlio Charles Mosseri 10% owner | Jun 30, 2026 | Buy | +50,000 | $18.32 | $916.00K | 3,186,576 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | Jun 30, 2026 | Buy | +12,500 | $20.00 | $250.00K | 3,688,424 |
| Kenneth Hoberman Director | Jun 11, 2026 | Award | +35,000 | – | – | 168,140 |
| Juan Sanchez Director | Jun 11, 2026 | Award | +35,000 | – | – | 113,380 |
| Matthew L. Kaplan Director | Jun 11, 2026 | Award | +35,000 | – | – | 159,760 |
| James F. Oliviero III Director | Jun 11, 2026 | Award | +35,000 | – | – | 122,828 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | Jan 6, 2026 | Award | +150,000 | – | – | 3,675,924 |
| Michael J. Carson Vice President, Finance | Jan 6, 2026 | Award | +61,200 | – | – | 200,118 |
| Enrique Poradosu Chief Science & Business Off | Jan 6, 2026 | Award | +150,000 | – | – | 1,806,319 |
| Shay Shemesh Chief Dev. & Ops. Officer | Jan 6, 2026 | Award | +150,000 | – | – | 1,793,068 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | Nov 5, 2025 | Buy | +5,000 | $5.72 | $28.60K | 3,525,924 |
| Juan Sanchez Director | Nov 5, 2025 | Buy | +13,000 | $5.79 | $75.27K | 78,150 |
| Matthew L. Kaplan Director | Nov 5, 2025 | Buy | +11,000 | $5.84 | $64.24K | 124,760 |
| Marlio Charles Mosseri 10% owner | Oct 27, 2025 | Buy | +72,836 | $6.28 | $457.41K | 3,136,576 |
| Marlio Charles Mosseri 10% owner | Oct 24, 2025 | Buy | +35,034 | $6.15 | $215.46K | 3,063,740 |
| Marlio Charles Mosseri 10% owner | Oct 23, 2025 | Buy | +46,900 | $6.06 | $284.21K | 3,028,706 |
| Juan Sanchez Director | Sep 22, 2025 | Award | +30,000 | – | – | 65,150 |
| Marlio Charles Mosseri 10% owner | Jun 20, 2025 | Buy | +5,603 | $7.99 | $44.77K | 2,981,806 |
| Marlio Charles Mosseri 10% owner | Jun 18, 2025 | Buy | +28,043 | $8.05 | $225.75K | 2,976,203 |
| Marlio Charles Mosseri 10% owner | Jun 17, 2025 | Buy | +5,399 | $8.11 | $43.79K | 2,948,160 |
| Matthew L. Kaplan Director | Jun 12, 2025 | Award | +30,000 | – | – | 113,760 |
| James F. Oliviero III Director | Jun 12, 2025 | Award | +30,000 | – | – | 87,828 |
| Kenneth Hoberman Director | Jun 12, 2025 | Award | +30,000 | – | – | 133,140 |
| Marlio Charles Mosseri 10% owner | May 12, 2025 | Buy | +21,167 | $8.11 | $171.66K | 2,942,761 |
| Marlio Charles Mosseri 10% owner | May 9, 2025 | Buy | +9,850 | $8.95 | $88.16K | 2,921,382 |
| Marlio Charles Mosseri 10% owner | May 9, 2025 | Buy | +9,817 | $8.90 | $87.37K | 2,931,199 |
| Marlio Charles Mosseri 10% owner | May 9, 2025 | Buy | +5,395 | $8.98 | $48.45K | 2,936,594 |
| Marlio Charles Mosseri 10% owner | May 8, 2025 | Buy | +100 | $8.99 | $899 | 2,909,032 |
| Marlio Charles Mosseri 10% owner | May 8, 2025 | Buy | +100 | $8.71 | $871 | 2,909,132 |
| Marlio Charles Mosseri 10% owner | May 8, 2025 | Buy | +2,400 | $8.97 | $21.53K | 2,911,532 |
| Marlio Charles Mosseri 10% owner | May 8, 2025 | Buy | +100 | $8.65 | $865 | 2,909,032 |
| Marlio Charles Mosseri 10% owner | May 8, 2025 | Buy | +100 | $8.65 | $865 | 2,909,132 |
| Marlio Charles Mosseri 10% owner | May 8, 2025 | Buy | +2,400 | $8.65 | $20.76K | 2,911,532 |
| Marlio Charles Mosseri 10% owner | May 8, 2025 | Buy | +50 | $8.65 | $433 | 2,908,932 |
| Marlio Charles Mosseri 10% owner | May 7, 2025 | Buy | +2,703 | $8.40 | $22.71K | 2,899,268 |
| Marlio Charles Mosseri 10% owner | May 7, 2025 | Buy | +9,614 | $8.64 | $83.06K | 2,908,882 |
| Marlio Charles Mosseri 10% owner | May 6, 2025 | Buy | +2,340 | $8.40 | $19.66K | 2,886,461 |
| Marlio Charles Mosseri 10% owner | May 6, 2025 | Buy | +10,104 | $8.64 | $87.30K | 2,896,565 |
| Marlio Charles Mosseri 10% owner | Feb 7, 2025 | Buy | +240,000 | $5.00 | $1.20M | 2,884,121 |
| Enrique Poradosu Chief Science & Business Off | Jan 2, 2025 | Award | +150,000 | – | – | 1,656,319 |
| Michael J. Carson Vice President, Finance | Jan 2, 2025 | Award | +51,000 | – | – | 138,918 |
| Shay Shemesh Chief Dev. & Ops. Officer | Jan 2, 2025 | Award | +150,000 | – | – | 1,643,068 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | Jan 2, 2025 | Award | +250,000 | – | – | 3,520,924 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | Dec 24, 2024 | Buy | +4,500 | $4.65 | $20.93K | 3,270,924 |
| Marlio Charles Mosseri 10% owner | Dec 13, 2024 | Buy | +17,000 | $4.70 | $79.90K | 2,612,000 |
| Marlio Charles Mosseri 10% owner | Dec 13, 2024 | Buy | +17,000 | $4.70 | $79.90K | 2,644,121 |
| Marlio Charles Mosseri 10% owner | Dec 12, 2024 | Buy | +32,121 | $4.64 | $149.04K | 2,627,121 |
| Enrique Poradosu Chief Science & Business Off | Nov 19, 2024 | Buy | +2,000 | $4.99 | $9.98K | 1,506,319 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | Nov 15, 2024 | Buy | +20,000 | $4.92 | $98.40K | 3,266,424 |
| Michael J. Carson Vice President, Finance | Nov 7, 2024 | Sale | −2,755 | $8.16 | $22.48K | 87,918 |
| James F. Oliviero III Director | Jun 13, 2024 | Award | +30,000 | – | – | 57,828 |
| Matthew L. Kaplan Director | Jun 13, 2024 | Award | +30,000 | – | – | 83,760 |
| Kenneth Hoberman Director | Jun 13, 2024 | Award | +30,000 | – | – | 103,140 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | May 14, 2024 | Buy | +1,940 | $6.74 | $13.08K | 3,246,424 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | May 10, 2024 | Buy | +2,000 | $6.40 | $12.80K | 3,244,484 |
| Shay Shemesh Chief Dev. & Ops. Officer | May 10, 2024 | Buy | +1,113 | $6.32 | $7.03K | 1,493,068 |
| Enrique Poradosu Chief Science & Business Off | May 10, 2024 | Buy | +500 | $6.29 | $3.15K | 1,504,319 |
| Ron Bentsur Chairman & CEO, Director, 10% owner | Mar 18, 2024 | Buy | +5,000 | $10.29 | $51.45K | 3,242,484 |
| Michael J. Carson Vice President, Finance | Jan 4, 2024 | Award | +34,567 | – | – | 90,673 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.